Tetracyclines increase lipid phosphate phosphatase expression on plasma membranes and turnover of plasma lysophosphatidate

• Author(s) / Creator(s)

  • Tang, Xiaoyun
  • Zhao, Yuan Y.
  • Dewald, Jay
  • Curtis, Jonathan M.
  • Brindley, David N.

• Extracellular lysophosphatidate and sphingosine 1-phosphate (S1P) are important bioactive lipids, which signal through G-protein-coupled receptors to stimulate cell growth and survival. The lysophosphatidate and S1P signals are terminated partly by degradation through three broad-specificity lipid phosphate phosphatases (LPPs) on the cell surface. Significantly, the expression of LPP1 and LPP3 is decreased in many cancers, and this increases the impact of lysophosphatidate and S1P signaling. However, relatively little is known about the physiological or pharmacological regulation of the expression of the different LPPs. We now show that treating several malignant and nonmalignant cell lines with 1 μg/ml tetracycline, doxycycline, or minocycline significantly increased the extracellular degradation of lysophosphatidate. S1P degradation was also increased in cells that expressed high LPP3 activity. These results depended on an increase in the stabilities of the three LPPs and increased expression on the plasma membrane. We tested the physiological significance of these results and showed that treating rats with doxycycline accelerated the clearance of lysophosphatidate, but not S1P, from the circulation. However, administering 100 mg/kg/day doxycycline to mice decreased plasma concentrations of lysophosphatidate and S1P. This study demonstrates a completely new property of tetracyclines in increasing the plasma membrane expression of the LPPs.

• Date created

  2016-01-01

• Subjects / Keywords

  • Matrix Metalloproteinase
  • Sphingosine 1-Phosphate
  • Doxycycline
  • Autotaxin

• Type of Item

  Article (Published)

• DOI

  https://doi.org/10.7939/r3-5q8q-ca88

• License

  © 2016 by the American Society for Biochemistry and Molecular Biology, Inc.